E
Sell
3/14/2023Downgrade
Braxia Scientific Corp. (BRAXF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the solvency index and volatility index. The quick ratio declined from 1.68 to 1.3.
D
Sell
2/23/2023Upgraded
Braxia Scientific Corp. (BRAXF) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
Braxia Scientific Corp. (BRAXF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the growth index, volatility index and efficiency index. Operating cash flow declined 193.73% from -$469.1 to -$1.38M, net income declined 136.71% from -$759 to -$1.8M, and earnings per share declined from -$0.0038 to -$0.008.
D
Sell
8/2/2022Upgraded
Braxia Scientific Corp. (BRAXF) was upgraded to D- from E+ on 8/2/2022 due to an increase in the growth index, volatility index and efficiency index. EBIT increased 27.09% from -$1.99M to -$1.45M, operating cash flow increased 25.66% from -$1.36M to -$1.01M, and total revenue increased 13.14% from $257.9 to $291.8.
E
Sell
5/5/2022Downgrade
Braxia Scientific Corp. (BRAXF) was downgraded to E+ from D- on 05/05/2022.
D
Sell
4/20/2022Upgraded
Braxia Scientific Corp. (BRAXF) was upgraded to D- from E+ on 4/20/2022 due to an increase in the valuation index.
E
Sell
11/23/2021Downgrade
Braxia Scientific Corp. (BRAXF) was downgraded to E+ from D- on 11/23/2021 due to a decline in the total return index and volatility index.
D
Sell
11/8/2021Upgraded
Braxia Scientific Corp. (BRAXF) was upgraded to D- from E+ on 11/8/2021 due to an increase in the valuation index.
E
Sell
9/3/2021Upgraded
Braxia Scientific Corp. (BRAXF) was upgraded to E+ from E on 9/3/2021 due to an increase in the valuation index.
E
Sell
5/6/2021None
Braxia Scientific Corp. (BRAXF) was downgraded to E from U on 05/06/2021.
